J. Michael French

This profile gathers the share dealings of J. Michael French across 2 companies, led by Marina Biotech, Inc. and Sirna Therapeutics Inc. We count 11 filings; the first trade dates from 21 February 2006 and the latest from 30 December 2014.

Purchases make up the whole of the open-market record (5 purchases, €5,044). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants.

In size, the median ticket on the buying side is €504.

Most recently, on 2 January 2015, the filings show a share grant worth €84k in Marina Biotech, Inc. The most recent open-market purchase was published on 11 August 2008, 6,648 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.